Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.